Metastatic potential of tumor-initiating cells in solid tumors

Frontiers in Bioscience

Volumn 16, Issue 5, 2011, Pages 1927-1938

  Adhikari, Amit S ^a   Agarwal, Neeraj ^a   Iwakuma, Tomoo ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ABCG2; Cancer stem cells; CD117; CXCR4; Metastasis; Osteosarcoma; Review; Side population; Solid tumors; Stro 1; Tumor initiating cells

Indexed keywords

ABC TRANSPORTER; ALDEHYDE DEHYDROGENASE; CD44 PROTEIN, HUMAN; HERMES ANTIGEN;

BONE TUMOR; BREAST TUMOR; CANCER STEM CELL; CELL SEPARATION; FEMALE; HUMAN; LUNG TUMOR; MALE; METASTASIS; METHODOLOGY; NEOPLASM; OSTEOSARCOMA; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE TUMOR; REVIEW; STOMACH TUMOR;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD44; ATP-BINDING CASSETTE TRANSPORTERS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL SEPARATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; OSTEOSARCOMA; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; STOMACH NEOPLASMS;

EID: 79953182594     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3831     Document Type: Article

References (103)

1. Lapidot, T., C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden, B. Paterson, M. A. Caligiuri & J. E. Dick: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367, 645-8 (1994) (Pubitemid 24067706)
2. Bonnet, D. & J. E. Dick: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3, 730-7 (1997) (Pubitemid 27298715)
3. Bjerkvig, R., B. B. Tysnes, K. S. Aboody, J. Najbauer & A. J. Terzis: Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer, 5, 899-904 (2005) (Pubitemid 41746034)
4. Clarke, M. F., J. E. Dick, P. B. Dirks, C. J. Eaves, C. H. Jamieson, D. L. Jones, J. Visvader, I. L. Weissman & G. M. Wahl: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res, 66, 9339-44 (2006) (Pubitemid 44623625)
5. Al-Hajj, M., M. S. Wicha, A. Benito-Hernandez, S. J. Morrison & M. F. Clarke: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A, 100, 3983-8 (2003) (Pubitemid 36418143)
6. Singh, S. K., C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani, T. Hide, R. M. Henkelman, M. D. Cusimano & P. B. Dirks: Identification of human brain tumour initiating cells. Nature, 432, 396-401 (2004) (Pubitemid 39551674)
7. O'Brien, C. A., A. Pollett, S. Gallinger & J. E. Dick: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-10 (2007) (Pubitemid 46067310)
8. Li, C., D. G. Heidt, P. Dalerba, C. F. Burant, L. Zhang, V. Adsay, M. Wicha, M. F. Clarke & D. M. Simeone: Identification of pancreatic cancer stem cells. Cancer Res, 67, 1030-7 (2007)
9. Patrawala, L., T. Calhoun-Davis, R. Schneider-Broussard & D. G. Tang: Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res, 67, 6796-805 (2007) (Pubitemid 47105527)
10. Eramo, A., F. Lotti, G. Sette, E. Pilozzi, M. Biffoni, A. Di Virgilio, C. Conticello, L. Ruco, C. Peschle & R. De Maria: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ, 15, 504-14 (2008) (Pubitemid 351267301)
11. Bertolini, G., L. Roz, P. Perego, M. Tortoreto, E. Fontanella, L. Gatti, G. Pratesi, A. Fabbri, F. Andriani, S. Tinelli, E. Roz, R. Caserini, S. Lo Vullo, T. Camerini, L. Mariani, D. Delia, E. Calabro, U. Pastorino & G. Sozzi: Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A, 106, 16281-6 (2009)
12. Curley, M. D., V. A. Therrien, C. L. Cummings, P. A. Sergent, C. R. Koulouris, A. M. Friel, D. J. Roberts, M. V. Seiden, D. T. Scadden, B. R. Rueda & R. Foster: CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells, 27, 2875-83 (2009)
13. Ma, S., K. W. Chan, L. Hu, T. K. Lee, J. Y. Wo, I. O. Ng, B. J. Zheng & X. Y. Guan: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology, 132, 2542-56 (2007) (Pubitemid 46890873)
14. Suva, M. L., N. Riggi, J. C. Stehle, K. Baumer, S. Tercier, J. M. Joseph, D. Suva, V. Clement, P. Provero, L. Cironi, M. C. Osterheld, L. Guillou & I. Stamenkovic: Identification of cancer stem cells in Ewing's sarcoma. Cancer Res, 69, 1776-81 (2009)
15. Wu, C., Q. Wei, V. Utomo, P. Nadesan, H. Whetstone, R. Kandel, J. S. Wunder & B. A. Alman: Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res, 67, 8216-22 (2007) (Pubitemid 47395158)
16. Murase, M., M. Kano, T. Tsukahara, A. Takahashi, T. Torigoe, S. Kawaguchi, S. Kimura, T. Wada, Y. Uchihashi, T. Kondo, T. Yamashita & N. Sato: Side population cells have the characteristics of cancer stem-like cells/cancerinitiating cells in bone sarcomas. Br J Cancer, 101, 1425-32 (2009)
17. Hirotsu, M., T. Setoguchi, Y. Matsunoshita, H. Sasaki, H. Nagao, H. Gao, K. Sugimura & S. Komiya: Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells. Br J Cancer, 101, 2030-7 (2009)
18. Levings, P. P., S. V. McGarry, T. P. Currie, D. M. Nickerson, S. McClellan, S. C. Ghivizzani, D. A. Steindler & C. P. Gibbs: Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res, 69, 5648-55 (2009)
19. Lobo, N. A., Y. Shimono, D. Qian & M. F. Clarke: The biology of cancer stem cells. Annu Rev Cell Dev Biol, 23, 675-99 (2007)
20. Malanchi, I. & J. Huelsken: Cancer stem cells: never Wnt away from the niche. Curr Opin Oncol, 21, 41-6 (2009)
21. Hirschmann-Jax, C., A. E. Foster, G. G. Wulf, J. G. Nuchtern, T. W. Jax, U. Gobel, M. A. Goodell & M. K. Brenner: A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A, 101, 14228-33 (2004) (Pubitemid 39305058)
22. Borst, P., J. Jonkers & S. Rottenberg: What makes tumors multidrug resistant? Cell Cycle, 6, 2782-7 (2007) (Pubitemid 350277170)
23. Hadnagy, A., L. Gaboury, R. Beaulieu & D. Balicki: SP analysis may be used to identify cancer stem cell populations. Exp Cell Res, 312, 3701-10 (2006) (Pubitemid 44633895)
24. Li, F., B. Tiede, J. Massague & Y. Kang: Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res, 17, 3-14 (2007) (Pubitemid 46096419)
25. Pandit, T. S., W. Kennette, L. Mackenzie, G. Zhang, W. Al-Katib, J. Andrews, S. A. Vantyghem, D. G. Ormond, A. L. Allan, D. I. Rodenhiser, A. F. Chambers & A. B. Tuck: Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment. Int J Oncol, 35, 297-308 (2009)
26. Marotta, L. L. & K. Polyak: Cancer stem cells: a model in the making. Curr Opin Genet Dev, 19, 44-50 (2009)
27. Lapidot, T. & O. Kollet: The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immunedeficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia, 16, 1992-2003 (2002) (Pubitemid 35203441)
28. Kang, H., G. Watkins, A. Douglas-Jones, R. E. Mansel & W. G. Jiang: The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast, 14, 360-7 (2005) (Pubitemid 41510192)
29. Kaplan, R. N., R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent, C. Costa, D. D. MacDonald, D. K. Jin, K. Shido, S. A. Kerns, Z. Zhu, D. Hicklin, Y. Wu, J. L. Port, N. Altorki, E. R. Port, D. Ruggero, S. V. Shmelkov, K. K. Jensen, S. Rafii & D. Lyden: VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature, 438, 820-7 (2005) (Pubitemid 41753060)
30. Dewan, M. Z., S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi & N. Yamamoto: Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother, 60, 273-6 (2006) (Pubitemid 44223937)
31. Ratajczak, M. Z., E. Zuba-Surma, M. Kucia, R. Reca, W. Wojakowski & J. Ratajczak: The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia, 20, 1915-24 (2006) (Pubitemid 44614878)
32. Nagano, O. & H. Saya: Mechanism and biological significance of CD44 cleavage. Cancer Sci, 95, 930-5 (2004) (Pubitemid 40089583)
33. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill & B. Seed: CD44 is the principal cell surface receptor for hyaluronate. Cell, 61, 1303-13 (1990)
34. Corbel, C., A. Lehmann & F. Davison: Expression of CD44 during early development of the chick embryo. Mech Dev, 96, 111-4 (2000) (Pubitemid 30625272)
35. Shipitsin, M., L. L. Campbell, P. Argani, S. Weremowicz, N. Bloushtain-Qimron, J. Yao, T. Nikolskaya, T. Serebryiskaya, R. Beroukhim, M. Hu, M. K. Halushka, S. Sukumar, L. M. Parker, K. S. Anderson, L. N. Harris, J. E. Garber, A. L. Richardson, S. J. Schnitt, Y. Nikolsky, R. S. Gelman & K. Polyak: Molecular definition of breast tumor heterogeneity. Cancer Cell, 11, 259-73 (2007) (Pubitemid 46349843)
36. Hurt, E. M., B. T. Kawasaki, G. J. Klarmann, S. B. Thomas & W. L. Farrar: CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer, 98, 756-65 (2008) (Pubitemid 351272625)
37. Corbeil, D., K. Roper, A. Hellwig, M. Tavian, S. Miraglia, S. M. Watt, P. J. Simmons, B. Peault, D. W. Buck & W. B. Huttner: The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem, 275, 5512-20 (2000) (Pubitemid 30115186)
38. Miki, J., B. Furusato, H. Li, Y. Gu, H. Takahashi, S. Egawa, I. A. Sesterhenn, D. G. McLeod, S. Srivastava & J. S. Rhim: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res, 67, 3153-61 (2007) (Pubitemid 46724852)
39. Monzani, E., F. Facchetti, E. Galmozzi, E. Corsini, A. Benetti, C. Cavazzin, A. Gritti, A. Piccinini, D. Porro, M. Santinami, G. Invernici, E. Parati, G. Alessandri & C. A. La Porta: Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer, 43, 935-46 (2007) (Pubitemid 46366698)
40. Adhikari, A. S., N. Agarwal, B. M. Wood, C. Porretta, B. Ruiz, R. R. Pochampally & T. Iwakuma: CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance. Cancer Res, 70, 4602-12 (2010)
41. Wolf, N. S., A. Kone, G. V. Priestley & S. H. Bartelmez: In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Exp Hematol, 21, 614-22 (1993) (Pubitemid 24212361)
42. Zhou, S., J. D. Schuetz, K. D. Bunting, A. M. Colapietro, J. Sampath, J. J. Morris, I. Lagutina, G. C. Grosveld, M. Osawa, H. Nakauchi & B. P. Sorrentino: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med, 7, 1028-34 (2001) (Pubitemid 32937383)
43. Wagner-Souza, K., H. R. Diamond, M. H. Ornellas, B. E. Gomes, A. Almeida-Oliveira, E. Abdelhay, L. F. Bouzas & V. M. Rumjanek: Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells. Int J Mol Med, 22, 237-42 (2008)
44. Moserle, L., M. Ghisi, A. Amadori & S. Indraccolo: Side population and cancer stem cells: therapeutic implications. Cancer Lett, 288, 1-9 (2010)
45. Nishii, T., M. Yashiro, O. Shinto, T. Sawada, M. Ohira & K. Hirakawa: Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci, 100, 1397-402 (2009)
46. Patrawala, L., T. Calhoun, R. Schneider-Broussard, J. Zhou, K. Claypool & D. G. Tang: Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res, 65, 6207-19 (2005) (Pubitemid 40994406)
47. Fukuda, K., Y. Saikawa, M. Ohashi, K. Kumagai, M. Kitajima, H. Okano, Y. Matsuzaki & Y. Kitagawa: Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol, 34, 1201-7 (2009)
48. Chiba, T., K. Kita, Y. W. Zheng, O. Yokosuka, H. Saisho, A. Iwama, H. Nakauchi & H. Taniguchi: Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology, 44, 240-51 (2006) (Pubitemid 44049156)
49. Shi, G. M., Y. Xu, J. Fan, J. Zhou, X. R. Yang, S. J. Qiu, Y. Liao, W. Z. Wu, Y. Ji, A. W. Ke, Z. B. Ding, Y. Z. He, B. Wu, G. H. Yang, W. Z. Qin, W. Zhang, J. Zhu, Z. H. Min & Z. Q. Wu: Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J Cancer Res Clin Oncol, 134, 1155-63 (2008)
50. Wang, J., L. P. Guo, L. Z. Chen, Y. X. Zeng & S. H. Lu: Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res, 67, 3716-24 (2007) (Pubitemid 46762157)
51. Ho, M. M., A. V. Ng, S. Lam & J. Y. Hung: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res, 67, 4827-33 (2007) (Pubitemid 46910191)
52. Huang, D., Q. Gao, L. Guo, C. Zhang, W. Jiang, H. Li, J. Wang, X. Han, Y. Shi & S. H. Lu: Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev, 18, 465-73 (2009)
53. Harris, M. A., H. Yang, B. E. Low, J. Mukherjee, A. Guha, R. T. Bronson, L. D. Shultz, M. A. Israel & K. Yun: Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res, 68, 10051-9 (2008)
54. Fukaya, R., S. Ohta, M. Yamaguchi, H. Fujii, Y. Kawakami, T. Kawase & M. Toda: Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett, 291, 150-7 (2010)
55. Kabashima, A., H. Higuchi, H. Takaishi, Y. Matsuzaki, S. Suzuki, M. Izumiya, H. Iizuka, G. Sakai, S. Hozawa, T. Azuma & T. Hibi: Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion. Int J Cancer, 124, 2771-9 (2009)
56. Wang, Y. H., F. Li, B. Luo, X. H. Wang, H. C. Sun, S. Liu, Y. Q. Cui & X. X. Xu: A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma, 56, 371-8 (2009)
57. Han, J. S. & D. L. Crowe: Tumor initiating cancer stem cells from human breast cancer cell lines. Int J Oncol, 34, 1449-53 (2009)
58. Nakanishi, T., S. Chumsri, N. Khakpour, A. H. Brodie, B. Leyland-Jones, A. W. Hamburger, D. D. Ross & A. M. Burger: Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling. Br J Cancer, 102, 815-26 (2010)
59. Schatton, T., G. F. Murphy, N. Y. Frank, K. Yamaura, A. M. Waaga-Gasser, M. Gasser, Q. Zhan, S. Jordan, L. M. Duncan, C. Weishaupt, R. C. Fuhlbrigge, T. S. Kupper, M. H. Sayegh & M. H. Frank: Identification of cells initiating human melanomas. Nature, 451, 345-9 (2008)
60. Burkert, J., W. R. Otto & N. A. Wright: Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol, 214, 564-73 (2008) (Pubitemid 351482271)
61. Mitsutake, N., A. Iwao, K. Nagai, H. Namba, A. Ohtsuru, V. Saenko & S. Yamashita: Characterization of side population in thyroid cancer cell lines: cancer stemlike cells are enriched partly but not exclusively. Endocrinology, 148, 1797-803 (2007) (Pubitemid 46457095)
62. Armstrong, L., M. Stojkovic, I. Dimmick, S. Ahmad, P. Stojkovic, N. Hole & M. Lako: Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells, 22, 1142-51 (2004) (Pubitemid 39636394)
63. Hess, D. A., T. E. Meyerrose, L. Wirthlin, T. P. Craft, P. E. Herrbrich, M. H. Creer & J. A. Nolta: Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood, 104, 1648-55 (2004) (Pubitemid 39202270)
64. Ginestier, C., M. H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C. G. Kleer, S. Liu, A. Schott, D. Hayes, D. Birnbaum, M. S. Wicha & G. Dontu: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 1, 555-67 (2007) (Pubitemid 350056407)
65. Croker, A. K., D. Goodale, J. Chu, C. Postenka, B. D. Hedley, D. A. Hess & A. L. Allan: High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med, 13, 2236-52 (2009)
66. Korkaya, H., A. Paulson, F. Iovino & M. S. Wicha: HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene, 27, 6120-30 (2008)
67. Charafe-Jauffret, E., C. Ginestier, F. Iovino, J. Wicinski, N. Cervera, P. Finetti, M. H. Hur, M. E. Diebel, F. Monville, J. Dutcher, M. Brown, P. Viens, L. Xerri, F. Bertucci, G. Stassi, G. Dontu, D. Birnbaum & M. S. Wicha: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res, 69, 1302-13 (2009)
68. Charafe-Jauffret, E., C. Ginestier, F. Iovino, C. Tarpin, M. Diebel, B. Esterni, G. Houvenaeghel, J. M. Extra, F. Bertucci, J. Jacquemier, L. Xerri, G. Dontu, G. Stassi, Y. Xiao, S. H. Barsky, D. Birnbaum, P. Viens & M. S. Wicha: Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res, 16, 45-55 (2010)
69. Ma, S., K. W. Chan, T. K. Lee, K. H. Tang, J. Y. Wo, B. J. Zheng & X. Y. Guan: Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res, 6, 1146-53 (2008)
70. Huang, E. H., M. J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J. Z. Fields, M. S. Wicha & B. M. Boman: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res, 69, 3382-9 (2009)
71. Wang, L., P. Park, H. Zhang, F. La Marca & C. Y. Lin: Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int J Cancer, In press (2010)
72. Rasheed, Z. A., J. Yang, Q. Wang, J. Kowalski, I. Freed, C. Murter, S. M. Hong, J. B. Koorstra, N. V. Rajeshkumar, X. He, M. Goggins, C. Iacobuzio-Donahue, D. M. Berman, D. Laheru, A. Jimeno, M. Hidalgo, A. Maitra & W. Matsui: Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst, 102, 340-51 (2010)
73. Hirschhaeuser, F., H. Menne, C. Dittfeld, J. West, W. Mueller-Klieser & L. A. Kunz-Schughart: Multicellular tumor spheroids: An underestimated tool is catching up again. J Biotechnol, 148, 3-15 (2010)
74. Reynolds, B. A., W. Tetzlaff & S. Weiss: A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci, 12, 4565-74 (1992)
75. Reynolds, B. A. & S. Weiss: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science, 255, 1707-10 (1992)
76. Ghods, A. J., D. Irvin, G. Liu, X. Yuan, I. R. Abdulkadir, P. Tunici, B. Konda, S. Wachsmann-Hogiu, K. L. Black & J. S. Yu: Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells, 25, 1645-53 (2007) (Pubitemid 47121841)
77. Lai, D. M., T. Liu, Y. Huang, L. H. Wang, J. Zhang & W. W. Cheng: [Identification and characterization of ovarian cancer stem-like cells from primary tumor.]. Zhonghua Fu Chan Ke Za Zhi, 44, 936-40 (2009)
78. Na, Y. R., S. H. Seok, D. J. Kim, J. H. Han, T. H. Kim, H. Jung, B. H. Lee & J. H. Park: Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4. Tumour Biol, 30, 300-9 (2009)
79. Feng, D., C. Peng, C. Li, Y. Zhou, M. Li, B. Ling, H. Wei & Z. Tian: Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncol Rep, 22, 1129-34 (2009)
80. Zhou, S., F. Li, J. Xiao, W. Xiong, Z. Fang, W. Chen & P. Niu: Isolation and identification of cancer stem cells from human osteosarcom by serum-free three-dimensional culture combined with anticancer drugs. J Huazhong Univ Sci Technolog Med Sci, 30, 81-4 (2010)
81. Gibbs, C. P., V. G. Kukekov, J. D. Reith, O. Tchigrinova, O. N. Suslov, E. W. Scott, S. C. Ghivizzani, T. N. Ignatova & D. A. Steindler: Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia, 7, 967-76 (2005)
82. Levina, V., A. M. Marrangoni, R. DeMarco, E. Gorelik & A. E. Lokshin: Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One, 3, e3077 (2008)
83. Li, L. & W. B. Neaves: Normal stem cells and cancer stem cells: the niche matters. Cancer Res, 66, 4553-7 (2006)
84. Balic, M., H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R. H. Datar & R. J. Cote: Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res, 12, 5615-21 (2006) (Pubitemid 44629587)
85. Hermann, P. C., S. L. Huber, T. Herrler, A. Aicher, J. W. Ellwart, M. Guba, C. J. Bruns & C. Heeschen: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1, 313-23 (2007) (Pubitemid 47355323)
86. Takaishi, S., T. Okumura, S. Tu, S. S. Wang, W. Shibata, R. Vigneshwaran, S. A. Gordon, Y. Shimada & T. C. Wang: Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells, 27, 1006-20 (2009)
87. Klarmann, G. J., E. M. Hurt, L. A. Mathews, X. Zhang, M. A. Duhagon, T. Mistree, S. B. Thomas & W. L. Farrar: Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis, 26, 433-46 (2009)
88. Eaton, C. L., M. Colombel, G. van der Pluijm, M. Cecchini, A. Wetterwald, J. Lippitt, I. Rehman, F. Hamdy & G. Thalman: Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer. Prostate, 70, 875-82 (2010)
89. Tirino, V., V. Desiderio, R. d'Aquino, F. De Francesco, G. Pirozzi, U. Galderisi, C. Cavaliere, A. De Rosa & G. Papaccio: Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS ONE, 3, e3469 (2008)
90. Di Fiore, R., A. Santulli, R. D. Ferrante, M. Giuliano, A. De Blasio, C. Messina, G. Pirozzi, V. Tirino, G. Tesoriere & R. Vento: Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol, 219, 301-13 (2009)
91. Fujii, H., K. Honoki, T. Tsujiuchi, A. Kido, K. Yoshitani & Y. Takakura: Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol, 34, 1381-6 (2009)
92. Maeda, S., H. Shinchi, H. Kurahara, Y. Mataki, K. Maemura, M. Sato, S. Natsugoe, T. Aikou & S. Takao: CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer, 98, 1389-97 (2008) (Pubitemid 351543575)
93. Quintana, E., M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson & S. J. Morrison: Efficient tumour formation by single human melanoma cells. Nature, 456, 593-8 (2008)
94. Hays, L. E.: Heterogeneity in the AML stem cell pool. Blood, 114, 3976-7 (2009)
95. Heuser, M., L. M. Sly, B. Argiropoulos, F. Kuchenbauer, C. Lai, A. Weng, M. Leung, G. Lin, C. Brookes, S. Fung, P. J. Valk, R. Delwel, B. Lowenberg, G. Krystal & R. K. Humphries: Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Blood, 114, 3983-93 (2009)
96. Zhang, M., F. Behbod, R. L. Atkinson, M. D. Landis, F. Kittrell, D. Edwards, D. Medina, A. Tsimelzon, S. Hilsenbeck, J. E. Green, A. M. Michalowska & J. M. Rosen: Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res, 68, 4674-82 (2008)
97. Kelly, P. N., A. Dakic, J. M. Adams, S. L. Nutt & A. Strasser: Tumor growth need not be driven by rare cancer stem cells. Science, 317, 337 (2007) (Pubitemid 47106366)
98. Iwasaki, H. & T. Suda: Cancer stem cells and their niche. Cancer Sci, 100, 1166-72 (2009)
99. Hiratsuka, S., K. Nakamura, S. Iwai, M. Murakami, T. Itoh, H. Kijima, J. M. Shipley, R. M. Senior & M. Shibuya: MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell, 2, 289-300 (2002) (Pubitemid 41043963)
100. Veeravagu, A., S. R. Bababeygy, M. Y. Kalani, L. C. Hou & V. Tse: The cancer stem cell-vascular niche complex in brain tumor formation. Stem Cells Dev, 17, 859-67 (2008)
101. Calabrese, C., H. Poppleton, M. Kocak, T. L. Hogg, C. Fuller, B. Hamner, E. Y. Oh, M. W. Gaber, D. Finklestein, M. Allen, A. Frank, I. T. Bayazitov, S. S. Zakharenko, A. Gajjar, A. Davidoff & R. J. Gilbertson: A perivascular niche for brain tumor stem cells. Cancer Cell, 11, 69-82 (2007) (Pubitemid 46054518)
102. Mani, S. A., W. Guo, M. J. Liao, E. N. Eaton, A. Ayyanan, A. Y. Zhou, M. Brooks, F. Reinhard, C. C. Zhang, M. Shipitsin, L. L. Campbell, K. Polyak, C. Brisken, J. Yang & R. A. Weinberg: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-15 (2008) (Pubitemid 351636299)
103. Hollier, B. G., K. Evans & S. A. Mani: The epithelial-tomesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia, 14, 29-43 (2009)